NCT01211470 - Initial Treatment for Acute Bacterial Skin Infections (ABSSSI) Caused by Staphylococcus Aureus | Biotech Hunter

Enrollment

215

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

March 31, 2012

Conditions

Acute Bacterial Skin and Skin-structure Infection(ABSSSI) Due to Staphylococcus Aureus (MSSA)(Susceptible or Methicillin Resistant)

Interventions

DRUG

Daptomycin

Active Comparator: Daptomycin.

DRUG

PMX-30063-investigational drug

Experimental: PMX-30063

Trial Locations (8)

Hamilton

Chicoutimi

Greenfield Park

Québec

Sherbrooke

Trois-Rivières

11 Sites, Multiple

5 Sites, Multiple